DOI: 10.1007/s00259-017-3884-0Pages: 1-8

Comparison of positron emission tomography/computed tomography and magnetic resonance imaging for posttherapy evaluation in patients with advanced cervical cancer receiving definitive concurrent chemoradiotherapy

1. Chang Gung Memorial Hospital Keelung Branch, Department of Nuclear Medicine

2. Chang Gung Memorial Hospital and Chang Gung University College of Medicine, Gynecologic Cancer Research Center

3. Chang Gung Memorial Hospital and Chang Gung University College of Medicine, Department of Medical Imaging and Intervention, Clinical Metabolomics Core Lab, Imaging Core Lab, Institute for Radiological Research

4. Chang Gung Memorial Hospital Keelung Branch, Department of Diagnostic Radiology

5. Chang Gung Memorial Hospital and Chang Gung University College of Medicine, Department of Nuclear Medicine and Molecular Imaging Center

6. Chang Gung Memorial Hospital and Chang Gung University College of Medicine, Department of Radiation Oncology

7. Chang Gung Memorial Hospital and Chang Gung University College of Medicine, Department of Obstetrics and Gynecology

Correspondence to:
Feng-Yuan Liu
Tel: +886-3-3281200
Email: billliu@cgmh.org.tw

Close

Abstract

Purpose

Our purpose was to assess the diagnostic performance of positron emission tomography/computed tomography (PET/CT) and pelvic/abdominal magnetic resonance imaging (MRI) after concurrent chemoradiotherapy (CCRT) for posttherapy evaluation in patients with advanced cervical cancer.

Methods

Patients with cervical squamous cell carcinoma, either with advanced FIGO stage or with positive pelvic or para-aortic lymph node (PALN), received PET/CT using [18F]fluorodeoxyglucose and MRI including diffusion-weighted imaging between 2 and 3 months after CCRT completion. PET/CT were interpreted independently by two nuclear medicine physicians and MRI by two radiologists using the same scoring system. Active residual tumor was proven by pathological confirmation or disease progression on imaging studies within one year after CCRT and the disease regions were classified as local, regional, PALN, or distant. Patient-based and region-based comparison was performed using the receiver operating characteristic curve analysis.

Results

The study included 55 patients and 15 (27%) patients had active residual tumor. The diagnostic performance of PET/CT is significantly superior to that of MRI in patient-based analysis (P = 0.025) and in the detection of local (P = 0.045) and regional (P = 0.014) disease. The patient-based sensitivity, specificity, and accuracy of PET/CT are 60%, 100%, and 89% while those of MRI are 27%, 100%, and 80%.

Conclusions

PET/CT is superior to MRI for posttherapy evaluation in patients with advanced cervical cancer 2–3 months after definitive CCRT, mainly for the detection of residual local and regional disease. Patients with negative or equivocal results should be followed up regularly due to suboptimal sensitivities of imaging.

To access the full text, please Sign in

If you have institutional access, please click here

  • Accepted: Nov 8, 2017
  • Online: Nov 20, 2017

Article Tools

eanm
EJNMMI Ad